Eye movement patterns in people taking long-term psychiatric medications, measured with the Gaize device
Studies whether an eye-tracking device can detect psychiatric medication use in adults.
Plain-language title generated from the registry record
Registry title: Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
Key facts
- Where
- Philadelphia, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07389473, who can take part
Where in United States
- GaizePhiladelphia, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Gaize
- Trial code
- NCT07389473
- Record updated
- 5 February 2026
- Original description
The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.Read full original descriptionShow less
An Observational Study to Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.
Inclusion: Adults aged between 18 and 65, having given written informed consent to participate in the research trial; Currently using a psychiatric medication as prescribed by a healthcare professional for longer than 3 months; Normal or corrected to normal vision using either glasses or contact lenses, or surgery.
Exclusion: Enrolled in, or participated in another clinical trial within 30 days before the study; Having a prosthetic eye, missing eye, or wearer of an eye patch LASIK or other eye surgery within the prior 21 days; Had your eyes dilated by a medical doctor in the previous 24 hours; Photosensitive epilepsy; Medical Conditions: Participants with medical conditions or medications that could significantly affect cognitive and motor functions are excluded. Participants with conditions such as Glaucoma, macular degeneration, cataracts, lazy eye (amblyopia), or optic neuritis, or genetic anisocoria (unequal pupil size) will be excluded; Pregnancy: Pregnant individuals will be excluded from the study due to the potential risks associated with psychiatric medications; History of Severe Motion Sickness: Participants with a history of severe motion sickness in VR environments may be excluded, as they may not tolerate the VR headset well; Diagnosed with clinical blindness; Current or past head inject/ traumatic brain injury (TBI); Potential participants who are unable to provide consent for the study.